FDA, Health Canada approve Polish moly
Article Thumbnail ImageMarch 11, 2010 -- The U.S. Food and Drug Administration (FDA) and Health Canada have approved the use of the Maria Research Reactor (Maria) in Poland as a site to irradiate highly enriched uranium targets for molybdenum-99 (Mo-99) production, according to healthcare technology firm Covidien of Dublin, Ireland.
Member Sign In:
  MemberID or E-mail Address:
  Password:
(?)

New AuntMinnie.com Members

Becoming a Member is FREE!

  • Real-time radiology-specific news
  • Case of the Day and Teaching Files
  • Focused topics digital communities
  • Lively, discussion groups
  • Medical imaging bookstore
  • SalaryScan
  • Job Boards
  • OnLine CMe/CE
  • Bookstore, market reports, more …
  • Conference Calendar
  • User-controlled eNewsletters
  • … registration is FREE and easy!
  • Covidien will use the Mo-99 from Maria to manufacture technetium-99m (Tc-99m). Patients should begin to benefit from Maria-produced Mo-99 in the U.S. and Canada later this month, the company said.

    Related Reading

    Covidien signs deal to produce Mo-99 at Polish reactor, February 17, 2010

    Covidien to halt generator production, January 22, 2010

    Covidien pharmaceutical sales dip in fiscal Q1, January 20, 2010

    Covidien to sell radiopharmacy business, December 17, 2009

    Covidien shows mixed results in Q4, fiscal 2009, November 20, 2009

    Copyright © 2010 AuntMinnie.com


    || About || Advertising || Bookstore || Breast MRI || Career Center || Case of the Day || Communities || Conferences || Contact Us || ECR News 2013 || Education || Equipment Classifieds || Facebook || Forums || Home || Links || Marketplace || Mobile || Molecular Breast Imaging || New Installations || News in Brief || People in the News || Privacy Policy || RSNA News 2012 || Reference || Salary Survey Results || Trends in Radiology || Twitter || Vendor Connect || Webinars || XML/RSS ||

    Copyright © 2013 AuntMinnie.com. All Rights Reserved.